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FIGURE 1 Regression of Breast Artery Calciﬁcation
Two mammograms taken 4 years apart, showing regression of breast artery calciﬁcation.
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985BAC has been reported to occur after renal transplant,
but this cannot fully explain our ﬁndings (3). The
dual assessment of mammograms with BAC re-
gression has diminished measurement error due to
interrater variability; however, some measurement
error may remain, due to between-mammogram
variability. Most of the regression found, however,
represented clear interruptions in chains of calcium
that were previously not interrupted, which was easy
to ascertain.
In conclusion, our study convincingly showed that
MAC is a reversible process in the population. Further
research into the causes of regression and possible
effective therapy is warranted.Eva J.E. Hendriks, MD*
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A Heart Stressed Out of Energy?Tako-tsubo cardiomyopathy (TTC) is an acute form
of left ventricular (LV) systolic dysfunction often
following intense stress, but its pathophysiology
remains elusive. Because of its reversible natural
course without much apparent myocyte damage, as
inferred by the lack of late gadolinium-enhanced
(LGE) cardiac magnetic resonance (CMR), it has been
a priori assumed that its evolution is benign (1).
Whatever the etiology of the acute insult, it is
important to establish the nature of this state of
intense myocardial contractile dysfunction with
preserved viability, as this may point to a potential
therapeutic target in those cases with a less favorable
clinical course. It is known that impaired cardiac
energetic status is directly linked to clinical and
subclinical LV dysfunction. We hypothesized that
impaired cardiac energetics may occur in acute
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follow-up.
We prospectively recruited 26 patients with a
clear-cut diagnosis of TTC (2) and 11 matched healthy
controls; all provided informed consent. Patients
underwent 31P-CMR spectroscopy (31P-CMRS) (3) and
imaging (inclusive of native T1 mapping with a 3(3)
3(3)5 scheme) on a 3-T Philips scanner (Best, the
Netherlands), short term (days 0 to 3) and at 4
months follow-up. 31P-CMRS was analyzed with
JMRUi-3 (University of Lyon, Lyon, France), LV
volumes/mass with CMRTools (Cardiovascular
Imaging Solutions, London, United Kingdom), wall
motion scored (1 ¼ normal, 2 ¼ hypokinetic, 3 ¼
akinetic, 4 ¼ dyskinetic) and T1 maps generated
with RelaxMaps (Philips)/Segment (Medviso, Lund,
Sweden). C-reactive protein (CRP) and troponin I
were recorded on admission. Follow-up 31P-CMRS
and imaging were achieved in 20 patients (3 device
implantations, 2 in-hospital deaths, 1 claustrophobia
were excluded).FIGURE 1 T1 Mapping and 31P-CMRS
(A) Left: T1 mapping of normal healthy control (a), mid-cavity tako-tsu
the right. Normal myocardium is color-coded green, whereas edematou
and red. Right: PCr/ATP ratio and whole myocardial T1 mapping in patie
follow-up; †p < 0.05 acute study versus healthy controls; ‡p < 0.05 fol
in 1 patient short term (d) and at follow-up (e). 31P-CMR ¼ 31P-cardiac
PCr ¼ phosphocreatine.Data are shown as mean  SD unless otherwise
stated. Comparisons between groups were performed
using independent/paired Student t tests with sig-
niﬁcance at p < 0.05.
The patients’ mean age was 63 years (range 41 to 87
years), and 92% were women. The majority presented
with chest pain (80%) and had a stressful trigger (73%),
widespread ST-segment elevation electrocardiogram
(70%), and apical ballooning variant (77%). The 12-h
troponin level was 3.45 ng/ml (range 0.22 to 11.97
ng/ml), and CRP was 21.5 (range <4 to 75).
Mean LV ejection fraction was reduced and LV
mass index increased during the acute study versus
healthy controls (54  12% vs. 66  4% and 77  15
g/m2 vs. 66  10 g/m2, respectively, p < 0.05 for both);
all normalized at follow-up. LGE was present in only
4 cases, as a transmural band at the hinge points of
the wall motion abnormality in 3 cases and as non-
conﬂuent small foci in another case.
A signiﬁcant increase in native whole myocardium
T1 relaxation time was seen during the acutebo (b), and apical ballooning patients (c). T1 scale bar is shown on
s myocardium has progressive hues of pale green, yellow, orange,
nts versus normal healthy controls. *p < 0.05 acute study versus
low-up study versus healthy controls. (B) Examples of cardiac spectra
magnetic resonance spectroscopy; ATP ¼ adenosine triphosphate;
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987presentation compared with healthy volunteers
(1,253  63 ms vs. 1,188  16 ms, p ¼ 0.004), and this
improved signiﬁcantly (1,196  29 ms) at follow-up
(p ¼ 0.01) (Figure 1A). The acute changes were driven
by both the T1 values measured from acutely
dysfunctional segments (T1 ¼ 1,279  86 ms, p ¼
0.03 vs. healthy controls) but also by the segments
with normal wall motion in the acute study (1,226 
49 ms, p ¼ 0.02 vs. healthy controls). At follow-up,
the T1 relaxation times signiﬁcantly improved
(1,177  42 ms) compared with the acute study in
the nondysfunctional segments (p ¼ 0.008), but this
improvement only showed a trend in the
previously dysfunctional myocardium (p ¼ 0.05),
which remained signiﬁcantly abnormal compared
with healthy controls (T1 ¼ 1,224  40 ms, p ¼ 0.013
vs. healthy controls), implying that a certain degree
of myocardial edema remains present until at least
this stage.
A profound decrease in resting cardiac energetic
status was seen during the acute tako-tsubo phase
compared with healthy volunteers (phosphocreatine/
adenosine triphosphate [PCr/ATP] ratio 1.1  0.39 vs.
1.9  0.43, p << 0.0001). The PCr/ATP ratio increased
to 1.5  0.48 at 4 months follow-up (p ¼ 0.018
compared with initial presentation) but remained
signiﬁcantly reduced compared with normal healthy
volunteers (p ¼ 0.02) (Figure 1B).
We demonstrate severe global edema associated
with profound cardiac energetic impairment with
incomplete resolution of both at 4 months. These
observations contribute to the understanding of TTC
pathophysiology.
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Structural Heart Disease:
All That Glitters Is Not GoldWe read with interest the article by O’Neill et al. (1)
describing the utility of 3-dimensional printing (3DP)
in caval valve implantation. Theirs is an interesting
extension of earlier work by Kim et al. (2). Both
groups provide glimpses into the true incremental
value of printing-graspable 3D models in structural
heart disease (SHD), namely, the ability to optimize
device selection through direct physical interaction.
Many hurdles must be crossed, however, before
3DP can become mainstream technology in SHD.
Sengupta et al. (3) raised the issue of cost-
effectiveness. Beyond that, several technical factors
must ﬁrst be standardized and validated.
First, the fundamentals of 3DP must be well under-
stood by the clinician. This includes an understanding
of details such as the following: 1) primary data
acquisition; 2) model extraction (image processing); 3)
printer speciﬁcations; and 4) material properties.
Attention to such detail will reveal technical discrep-
ancies that could inﬂuence clinical results. One author
provided a proof-of-concept report testing the cost-
effectiveness and anatomic accuracy of 3DP (4);
however, larger scale studies are needed.
Second, the role of image processing is critical and
yet underappreciated. As in all clinical imaging, the
balance between signal and noise must be maintained.
Similar precaution applies to imaging-derived 3DP.
Kim et al. (2) describe multistep model extraction
